HIF1A and prostate carcinoma: A potent anti-invasive activity was also observed in prostate cancer PC-3M cells treated with 32, attenuating their invasiveness and cell migration and selectively suppressing hypoxia-induced HIF-1 activation in T47D breast tumor cells [171].